{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-002682","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.995364+00:00","generated_at":"2026-05-16T05:39:25.678551+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NRx Pharmaceuticals appoints Joseph M. Casper as COO; base salary $250,000 plus options","bullets":["Joseph M. Casper appointed Chief Operating Officer effective January 27, 2026.","Casper has 35 years of healthcare experience including Deloitte, Kaiser Permanente, and Anthem.","Annual base salary of $250,000 with a bonus of 25% subject to milestones with CEO.","Granted 100,000 options: 33.3% vest June 1, 2026, 33.3% Dec 1, 2026, 33.3% Dec 1, 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-002682","json":"https://secwatch.observer/filing/0001437749-26-002682.json","markdown":"https://secwatch.observer/filing/0001437749-26-002682.md","text":"https://secwatch.observer/filing/0001437749-26-002682.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926002682/0001437749-26-002682-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926002682/nrxp20260202_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:39:25.678551+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}